Glenmark To Conduct Trials For Potential COVID-19 Drug, Shares Jump

Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.

from NDTV Profit - Latest https://ift.tt/3aJ0G5i